Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic signatures for sudden cardiac death and related intermediate phenotypes.

Heart rhythm - 1 Aug 2026

Park Hanjin, Kim Daehoon, Jang Eunsun, Yu Hee Tae, Kim Tae-Hoon, Uhm Jae-Sun, Sung Jung-Hoon, Pak Hui-Nam, Lee Moon-Hyoung, Yang Pil-Sung, Joung Boyoung

Abstract excerpt

BACKGROUND: Novel markers for sudden cardiac death (SCD) are needed. OBJECTIVE: This study aimed to explore whether a protein risk score derived from a large-scale proteomics dataset improves risk prediction of SCD in the general population. METHODS: A total of 52,705 individuals with 1459 unique plasma protein measurements were included from the UK Biobank Pharma Proteomics Project. A protein risk score was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Blood Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death, Sudden, Cardiac

Share to Proteomics

Share to Risk Assessment

Share to Risk Factors

Share to UK Biobank

Share to United Kingdom

Source

Identifiers

PMID: 41780576
DOI: 10.1016/j.hrthm.2026.02.039

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic signatures for sudden cardiac death and related intermediate phenotypes.PMID 41780576Read ↗

Sudden Cardiac Death (SCD) – risk stratification and prediction with molecular biomarkersSemantic proximity Read ↗

Sex-specific proteomic signatures improve cardiovascular risk prediction for the general population without cardiovascular disease or diabetesSemantic proximity Read ↗

Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced predictionSemantic proximity Read ↗

A plasma proteomic signature for atherosclerotic cardiovascular disease risk prediction in the UK Biobank cohortSemantic proximity Read ↗

Plasma proteomic architecture of incident valvular heart disease in the UK Biobank: discovery, genetic prioritization, and exploratory risk discriminationSemantic proximity Read ↗

Large-scale identification of protein biomarkers and therapeutic targets in heart and brain disease.Semantic proximity Read ↗

Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathySemantic proximity Read ↗

Large-Scale Identification of Novel Protein Biomarkers and Therapeutic Targets in Heart and Brain DiseaseSemantic proximity Read ↗

Early identification of risk factors for sudden cardiac death.Semantic proximity Read ↗

Untargeted Proteomic Profiling Identifies Candidate Biomarkers for Early Detection of Cardiovascular Disease and MortalitySemantic proximity Read ↗

Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.Semantic proximity Read ↗

Risk stratification and management of sudden cardiac death: a new paradigm.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.